Steven M Paul - Net Worth and Insider Trading
Steven M Paul Net Worth
The estimated net worth of Steven M Paul is at least $169 Million dollars as of 2024-04-26. Steven M Paul is the Director of Bright Horizons Family Solutions Inc and owns about 763,650 shares of Bright Horizons Family Solutions Inc (BFAM) stock worth over $81 Million. Steven M Paul is the EVP, Science and Technology of Eli Lilly and Co and owns about 50,300 shares of Eli Lilly and Co (LLY) stock worth over $36 Million. Steven M Paul is also the PRESIDENT & CEO of Karuna Therapeutics Inc and owns about 108,849 shares of Karuna Therapeutics Inc (KRTX) stock worth over $36 Million. Besides these, Steven M Paul also holds Sage Therapeutics Inc (SAGE) , Voyager Therapeutics Inc (VYGR) , Alnylam Pharmaceuticals Inc (ALNY) . Details can be seen in Steven M Paul's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Steven M Paul has not made any transactions after 2021-08-18 and currently still holds the listed stock(s).
Transaction Summary of Steven M Paul
Steven M Paul Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Steven M Paul owns 5 companies in total, including Alnylam Pharmaceuticals Inc (ALNY) , Karuna Therapeutics Inc (KRTX) , and Sage Therapeutics Inc (SAGE) among others .
Click here to see the complete history of Steven M Paul’s form 4 insider trades.
Insider Ownership Summary of Steven M Paul
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ALNY | Alnylam Pharmaceuticals Inc | 2020-12-18 | director |
KRTX | Karuna Therapeutics Inc | 2021-08-18 | director & President & CEO |
SAGE | Sage Therapeutics Inc | 2019-03-21 | director |
VYGR | Voyager Therapeutics Inc | 2016-01-14 | director & President and CEO |
LLY | Eli Lilly and Co | 2008-02-04 | EVP & Science and Technology |
Steven M Paul Latest Holdings Summary
Steven M Paul currently owns a total of 6 stocks. Among these stocks, Steven M Paul owns 763,650 shares of Bright Horizons Family Solutions Inc (BFAM) as of May 1, 2015, with a value of $81 Million and a weighting of 48.05%. Steven M Paul owns 50,300 shares of Eli Lilly and Co (LLY) as of February 4, 2008, with a value of $36 Million and a weighting of 21.58%. Steven M Paul also owns 108,849 shares of Karuna Therapeutics Inc (KRTX) as of August 18, 2021, with a value of $36 Million and a weighting of 21.25%. The other 3 stocks Sage Therapeutics Inc (SAGE) , Voyager Therapeutics Inc (VYGR) , Alnylam Pharmaceuticals Inc (ALNY) have a combined weighting of 9.12% among all his current holdings.
Latest Holdings of Steven M Paul
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
BFAM | Bright Horizons Family Solutions Inc | 2015-05-01 | 763,650 | 106.28 | 81,160,722 |
LLY | Eli Lilly and Co | 2008-02-04 | 50,300 | 724.87 | 36,460,961 |
KRTX | Karuna Therapeutics Inc | 2021-08-18 | 108,849 | 329.83 | 35,901,666 |
SAGE | Sage Therapeutics Inc | 2019-03-21 | 646,830 | 13.58 | 8,783,951 |
VYGR | Voyager Therapeutics Inc | 2016-01-14 | 872,351 | 7.42 | 6,472,844 |
ALNY | Alnylam Pharmaceuticals Inc | 2020-12-18 | 1,000 | 143.71 | 143,710 |
Holding Weightings of Steven M Paul
Steven M Paul Form 4 Trading Tracker
According to the SEC Form 4 filings, Steven M Paul has made a total of 0 transactions in Bright Horizons Family Solutions Inc (BFAM) over the past 5 years. The most-recent trade in Bright Horizons Family Solutions Inc is the sale of 20,000 shares on May 1, 2015, which brought Steven M Paul around $1 Million.
According to the SEC Form 4 filings, Steven M Paul has made a total of 0 transactions in Eli Lilly and Co (LLY) over the past 5 years. The most-recent trade in Eli Lilly and Co is the sale of 19,822 shares on February 4, 2008, which brought Steven M Paul around $1 Million.
According to the SEC Form 4 filings, Steven M Paul has made a total of 3 transactions in Karuna Therapeutics Inc (KRTX) over the past 5 years, including 2 buys and 1 sells. The most-recent trade in Karuna Therapeutics Inc is the acquisition of 2,364 shares on August 18, 2021, which cost Steven M Paul around $250,253.
More details on Steven M Paul's insider transactions can be found in the Insider Trading History of Steven M Paul table.Insider Trading History of Steven M Paul
- 1
Steven M Paul Trading Performance
GuruFocus tracks the stock performance after each of Steven M Paul's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Steven M Paul is -0.42%. GuruFocus also compares Steven M Paul's trading performance to market benchmark return within the same time period. The performance of stocks bought by Steven M Paul within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Steven M Paul's insider trading performs compared to the benchmark.
Performance of Steven M Paul
Average Return
193.27%
Outperforming Transactions
67%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | -4.79 | -0.42 | 89.87 | 193.27 | 63.67 | 33.97 |
Relative Return to S&P 500(%) | -5 | -5.74 | 82.68 | 187.27 | 50.06 | 24.25 |
Steven M Paul Ownership Network
Ownership Network List of Steven M Paul
Ownership Network Relation of Steven M Paul
Steven M Paul Owned Company Details
What does Alnylam Pharmaceuticals Inc do?
Who are the key executives at Alnylam Pharmaceuticals Inc?
Steven M Paul is the director of Alnylam Pharmaceuticals Inc. Other key executives at Alnylam Pharmaceuticals Inc include EVP & Chief Commercial Officer Tolga Tanguler , CMO & EVP Dev & Med Affairs Pushkal Garg , and EVP & CLO & Secretary Indrani Lall Franchini .
Alnylam Pharmaceuticals Inc (ALNY) Insider Trades Summary
Over the past 18 months, Steven M Paul made no insider transaction in Alnylam Pharmaceuticals Inc (ALNY). Other recent insider transactions involving Alnylam Pharmaceuticals Inc (ALNY) include a net sale of 30,567 shares made by Pushkal Garg , a net sale of 7,095 shares made by Indrani Lall Franchini , and a net sale of 14,604 shares made by Yvonne Greenstreet .
In summary, during the past 3 months, insiders sold 36,501 shares of Alnylam Pharmaceuticals Inc (ALNY) in total and bought 0 shares, with a net sale of 36,501 shares. During the past 18 months, 159,676 shares of Alnylam Pharmaceuticals Inc (ALNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 159,676 shares.
Alnylam Pharmaceuticals Inc (ALNY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alnylam Pharmaceuticals Inc Insider Transactions
Steven M Paul Mailing Address
Above is the net worth, insider trading, and ownership report for Steven M Paul. You might contact Steven M Paul via mailing address: C/o Eli Litty & Co, Liiy Corporate Center Dc 1093, Indianapolis In 46285.